The Norwayz Tablet contains 45mg of Idebenone as the active ingredient. Idebenone is a synthetic benzoquinone, structurally related to coenzyme Q10, and functions as a potent antioxidant in the body. This medication is primarily indicated for the treatment of neuromuscular disorders associated with Idebenone deficiency, such as Friedreich's ataxia, and for the symptomatic treatment of idiopathic mitochondrial myopathy. The Norwayz Tablet is intended for oral administration and should be used under professional medical supervision. It is crucial to adhere to the prescribed dosage and duration of treatment to ensure effective therapy and minimize potential side effects. Consult a healthcare provider for detailed information on the usage, contraindications, and precautions before initiating treatment with the Norwayz Tablet.